China Resources Pharmaceutical Group Ltd. (3320) Financial Statements

4 Followers

China Resources Pharmaceutical Group Ltd. Financial Overview

China Resources Pharmaceutical Group Ltd.'s market cap is currently HK$32.35B. The company's EPS TTM is HK$; its P/E ratio is 3.24; and it has a dividend yield of 2.95%. China Resources Pharmaceutical Group Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 292.36B	HK$ 274.18B	HK$ 270.40B	HK$ 254.11B	HK$ 236.81B
Gross Profit	HK$ 48.27B	HK$ 43.30B	HK$ 42.18B	HK$ 39.13B	HK$ 35.38B
Operating Income	HK$ 13.43B	HK$ 12.90B	HK$ 11.66B	HK$ 10.81B	HK$ 9.25B
EBITDA	HK$ 17.85B	HK$ 15.45B	HK$ 15.43B	HK$ 15.47B	HK$ 11.95B
Net Income	HK$ 4.39B	HK$ 3.57B	HK$ 3.85B	HK$ 3.50B	HK$ 3.08B
Balance Sheet
Cash & Short-Term Investments	HK$ 58.73B	HK$ 17.48B	HK$ 59.27B	HK$ 32.52B	HK$ 37.32B
Total Assets	HK$ 318.34B	HK$ 274.28B	HK$ 271.48B	HK$ 243.93B	HK$ 248.56B
Total Debt	HK$ 104.87B	HK$ 73.43B	HK$ 62.16B	HK$ 63.85B	HK$ 67.96B
Net Debt	HK$ 74.26B	HK$ 55.95B	HK$ 37.51B	HK$ 42.88B	HK$ 42.63B
Total Liabilities	HK$ 187.52B	HK$ 169.90B	HK$ 169.20B	HK$ 150.24B	HK$ 152.69B
Stockholders' Equity	HK$ 57.26B	HK$ 51.34B	HK$ 50.60B	HK$ 49.56B	HK$ 50.98B
Cash Flow
Free Cash Flow	HK$ 16.93B	HK$ 14.55B	HK$ 12.42B	HK$ 7.54B	HK$ 8.32B
Operating Cash Flow	HK$ 20.48B	HK$ 17.55B	HK$ 15.55B	HK$ 10.90B	HK$ 11.22B
Investing Cash Flow	HK$ -10.07B	HK$ -8.89B	HK$ -2.07B	HK$ -3.30B	HK$ -8.83B
Financing Cash Flow	HK$ -10.96B	HK$ -16.84B	HK$ -4.07B	HK$ -9.00B	HK$ 5.31B

Currency in HKD

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

Income Statement >

China Resources Pharmaceutical Group Ltd. Debt to Assets

Balance Sheet >

China Resources Pharmaceutical Group Ltd. Cash Flow

Cash Flow >

China Resources Pharmaceutical Group Ltd. Forecast EPS vs Actual EPS

Earnings >